文献速递胃肠动力与功能性疾病

罗马IV功能性排便障碍:症状标准是否需要修改以提高临床相关性?

Rome IV Functional Defecation Disorder: Time for a Change in Symptom Criteria for Improved Clinical Relevance?
PubMed 文献 · Am J Gastroenterol · 2024-12-30

本研究在485例有排便症状的患者中检验罗马IV功能性排便障碍(FDD)标准,以生物反馈治疗反应作为验证工具,发现罗马IV FDD对生物反馈疗效的预测并不优于非罗马IV FDD,作者认为罗马IV症状标准需修订以纳入更多排便症状、所有亚型肠易激综合征及稀便或排便频繁者。

要点

  • 罗马IV FDD标准对生物反馈疗效的预测并不优于非罗马IV FDD(P=NS)。
  • 手指辅助排便(P=0.043)和累积排便症状数增加(P=0.038)与生物反馈改善相关。
  • 仅生理异常者生物反馈应答率83%,无罗马IV生理异常者为73%,差异无统计学意义。

核心结论

  • 罗马IV FDD标准对生物反馈疗效的预测并不优于非罗马IV FDD(P=NS)。
  • 作者认为罗马IV症状标准需修订,以纳入更多排便症状、所有亚型肠易激综合征及稀便或排便频繁者。
  • 作者认为在罗马FDD诊断中继续纳入生理学标准似乎是合理的。

研究设计与样本

  • 共485例(女性437例,平均年龄50±17.6岁)因排便症状就诊于神经胃肠病门诊的患者,无论是否符合正式罗马IV FDD标准均接受肛门直肠生物反馈治疗。
  • 采用罗马问卷、便秘问卷、满意度/控制力/生活质量视觉模拟量表及肛门直肠测压进行全面评估。

主要发现

  • 罗马IV FDD对生物反馈疗效的预测并不优于非罗马IV FDD(P=NS)。
  • 手指辅助排便(P=0.043)和累积排便症状数增加(P=0.038)与生物反馈改善(排便满意度增加≥2分)相关。
  • 仅生理异常者生物反馈应答率为83%,无罗马IV生理异常者为73%,差异无统计学意义。
  • 累积生理异常因素数增加与生物反馈疗效相关呈趋势(P=0.086)。

临床怎么用

  • 作者认为罗马IV症状标准需修订,以纳入更多排便症状、所有亚型肠易激综合征及稀便或排便频繁者。
  • 作者认为在罗马FDD诊断中继续纳入生理学标准似乎是合理的。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Defecatory disorders are common affecting up to 8% of the population. Rome IV diagnostic criteria are used to define this condition and, therefore, select patients for the gold standard therapy, anorectal biofeedback. The aim of this study was to test the current Rome IV Functional Defecation Disorder (FDD) criteria in a real-world population by using the response to biofeedback as a validation tool. METHODS: A total of 485 patients (female 437, mean age 50 ± 17.6 years) with defecatory symptoms presenting to a neurogastroenterology clinic underwent anorectal biofeedback therapy regardless of whether they met formal Rome IV FDD criteria or not. Patients were assessed extensively with the Rome questionnaire, constipation questionnaire, and visual analog scales for satisfaction, control, quality of life, and anorectal manometry. RESULTS: Rome IV FDD was no better at predicting response to biofeedback compared with non-Rome IV FDD ( P = NS). Digitation ( P = 0.043) and increasing cumulative number of defecatory symptoms ( P = 0.038) were correlated with improvement in biofeedback (≥2-point increase in bowel satisfaction). Those with abnormal physiology only responded well to biofeedback (83% response rate), but this was not statistically different from no Rome IV physiology patients (73%). There was a trend for increasing cumulative number of abnormal physiology factors to correlate with biofeedback ( P = 0.086). DISCUSSION: Rome IV symptom criteria need revision to include more defecatory symptoms, include all subtypes of irritable bowel syndrome, and be inclusive of those with either loose stools or more frequent stools such as those previously labeled with "pseudodiarrhea" or "hyperdefecation." Continuing to include physiology criteria in the Rome diagnosis of FDD seems valid.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Park CJ, Jones MP, Prott G, et al. Rome IV Functional Defecation Disorder: Time for a Change in Symptom Criteria for Improved Clinical Relevance? Am J Gastroenterol. 2024. PMID: 39787361. doi:10.14309/ajg.0000000000003267

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。